Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Chimeric monoclonal antibody against claudin-18 splice variant 2

EU orphan designation number: EU/3/10/803   
Active ingredient: Chimeric monoclonal antibody against claudin-18 splice variant 2
Indication: Treatment of gastric cancer
Sponsor: Astellas Pharma Europe B.V.
Sylviusweg 62, 2333 BE Leiden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/12/2010 Orphan designation EMA/OD/083/10 (2010)8587 of 26/11/2010
24/10/2014 Change of name and/or address of sponsor
22/05/2017 Change of name and/or address of sponsor
28/03/2018 Transfer of orphan designation EMA/OD/083/10/T/01 (2018)2007 of 26/03/2018